WC Walker & Associates’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$321K Buy
976
+93
+11% +$33K 0.17% 64
2022
Q3
$316K Hold
883
0.18% 63
2022
Q2
$293K Hold
883
0.17% 61
2022
Q1
$267K Hold
883
0.14% 64
2021
Q4
$215K Hold
883
0.11% 68
2021
Q3
$204K Hold
883
0.11% 65
2021
Q2
$207K Buy
+883
New +$177K 0.11% 66

Other funds holding LLY

WC Walker & Associates's LLY Position: Q4 2022 in Review

WC Walker & Associates increased its Eli Lilly (LLY) stake by 11% in Q4 2022, buying an estimated $33K and bringing the position to 976 shares worth $321K. The position accounts for 0.17% of the portfolio, ranked #64.

WC Walker & Associates first reported a position in LLY in Q2 2021 and has held it in 7 quarters since. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • WC Walker & Associates held 976 shares of Eli Lilly worth $321K as of Q4 2022.
  • WC Walker & Associates bought 93 Eli Lilly shares in Q4 2022, an estimated $33K.
  • Eli Lilly made up 0.17% of WC Walker & Associates's portfolio in Q4 2022, its #64 holding.
  • WC Walker & Associates first reported a position in Eli Lilly in Q2 2021 and has held it in 7 quarters since.
  • 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on WC Walker & Associates's 13F filing for Q4 2022, filed 23 Feb 2023.